Abstract:OBJECTIVE:The bone marrow mesenchymal stem cells (BMSCs) have the capacity to differentiate into insulin-producing cells (IPCs) in vitro. However, low differentiation efficiency and poor maturity are the main obstacles. To investigate the feasibility of BMSCs differentiation into IPCs in diabetic pancreatic microenvironment of pigs. METHODS:BMSCs were isolated and purified from the bone marrow of a 4-week-old male pig. Fifteen female pigs (aged 8 to 10 weeks, weighing 8 to 10 kg) were randomly divided into 3 groups: normal control group (group A, n=5), diabetic control group (group B, n=5), and BMSCs transplanted group (group C, n=5). The pigs of groups B and C were treated by auris vein injections of streptozocin and alloxan for 3 days to induce diabetes mellitus (DM) model, whose blood glucose level 2 days all greater than 17 mmol/L was successful DM model. A total of 1.1 mL of the 3rd passage BMSCs labeled with enhanced green fluorescent protein (EGFP), with cell density of 5 x 10(7)/ mL, were injected into subcapsular pancreas of group C at multiple points, normal saline at the same dosage into those of groups A and B. After 30 days of monitoring blood glucose, the histological analysis of islet number and size were done; the immunofluorescence staining was used to detect the protein expression of insulin in the new-formed islets. The EGFP+ cells were collected from the sections using laser-capture microdissection; RT-PCR was used to detect insulin mRNA and pancreatic and duodenal homeobox factor 1 (PDX1) mRNA expressions from EGFP+ cells, and the insulin and sex determining region of the Y chromosome (SRY) genes were detected by fluorescence in situ hybridization (FISH). RESULTS:The blood glucose level decreased significantly in group C when compared with that in group B from 18 days and gradually decreased with time (P < 0.05). The histological observation showed that the number of islets was increased significantly in group C when compared with that in group B (10.9 +/- 2.2 vs. 4.6 +/- 1.4, P < 0.05), and there was no significant difference when compared with that in group A (10.9 +/- 2.2 vs.12.6 +/- 2.6, P > 0.05). The size of new-formed islets in group C was significantly smaller than that in group A [(47.2 +/- 19.6) microm vs. (119.6 +/- 27.7) microm, P < 0.05]. The immunofluorescence staining showed that new-formed islets of group C expressed insulin protein. RT-PCR showed that the microdissected EGFP+ cells of group C expressed insulin mRNA and PDX-1 mRNA. FISH showed that the new-formed islet cells of group C contained SRY gene in Y chromosome and insulin double positive cells. CONCLUSION:BMSCs can differentiate into IPCs in diabetic pancreatic microenvironment of pigs.

Generation of Insulin-Producing Cells from PDX1 and NKX6.1 Gene-Modified Bone Marrow Mesenchymal Stem Cells

Generation of Insulin-Producing Cells from Bone Marrow Mesenchymal Stem Cells with Modified Expression of PDX1 and NKX6.1

Generation of Insulin-Producing Cells from PDX-1 Gene-Modified Human Mesenchymal Stem Cells.

In Vivo And In Vitro Characterization Of Insulin-Producing Cells Obtained From Murine Bone Marrow

IN VITRO TRANSDIFFERENTIATION OF RAT BONE MARROW MESENCHYMAL STEM CELLS INTO INSULIN-SECRETING CELLS

A preliminary study on recruitment of the bone marrow-derived stem cells into streptozotocin-induced diabetic mice

Studies on insulin-producing cells induced from mouse adipose mesenchymal stem cells

Studies on Coexpression of PDX1 and Betacellulin in Bone Marrow Mesen-chymal Stem Cells Differentiating into Insulin-secreting Cells

Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells in Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia

Human Expandable Pancreatic Progenitor–derived Β Cells Ameliorate Diabetes

Bone Marrow Mesenchymal Stem Cells Orthotopictransplantation Reverse Diabetes

Differentiation of bone marrow mesenchymal stem cells into insulin-producing cells: A dynamic observation

Direct Differentiation of Bone Marrow Mononucleated Cells Into Insulin-Producing Cells Using 4 Specific Soluble Factors

[Feasibility of Bone Marrow Mesenchymal Stem Cells Differentiation in Diabetic Pancreatic Microenvironment].

Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro.

PDX1 gene and cytokines induce human umbilical cord mesenchymal stem cells to differentiate into islet β-like cells in vitro

Coexpression of Pdx1 and betacellulin in mesenchymal stem cells could promote the differentiation of nestin-positive epithelium-like progenitors and pancreatic islet-like spheroids.

Transplantation of bone marrow derived cells promotes pancreatic islet repair in diabetic mice.

In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long-term culture running risk of malignant transformation.

Generation of Pancreatic Insulin-Producing Cells from Rhesus Monkey Induced Pluripotent Stem Cells

Generation of Insulin-Producing Cells from C3H10T1/2 Mesenchymal Progenitor Cells